PuSH - Publication Server of Helmholtz Zentrum München

von Schledorn, L.* ; Puertollano Martín, D.* ; Cleve, N.* ; Zöllner, J.* ; Roth, D. ; Staar, B.O.* ; Hegermann, J.* ; Ringshausen, F.C.* ; Nawroth, J. ; Martin, U.* ; Olmer, R.*

Primary ciliary dyskinesia patient-specific hiPSC-derived airway epithelium in air-liquid interface culture recapitulates disease specific phenotypes in vitro.

Cells 12:19 (2023)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Primary ciliary dyskinesia (PCD) is a rare heterogenic genetic disorder associated with perturbed biogenesis or function of motile cilia. Motile cilia dysfunction results in diminished mucociliary clearance (MCC) of pathogens in the respiratory tract and chronic airway inflammation and infections successively causing progressive lung damage. Current approaches to treat PCD are symptomatic, only, indicating an urgent need for curative therapeutic options. Here, we developed an in vitro model for PCD based on human induced pluripotent stem cell (hiPSC)-derived airway epithelium in Air-Liquid-Interface cultures. Applying transmission electron microscopy, immunofluorescence staining, ciliary beat frequency, and mucociliary transport measurements, we could demonstrate that ciliated respiratory epithelia cells derived from two PCD patient-specific hiPSC lines carrying mutations in DNAH5 and NME5, respectively, recapitulate the respective diseased phenotype on a molecular, structural and functional level.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
6.000
0.000
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Pcd ; Air-liquid Interface Culture ; Human Induced Pluripotent Stem Cells; Pluripotent Stem-cells; Scalable Expansion; Beat Pattern; Mutations; Generation; Defects; Model
Language english
Publication Year 2023
HGF-reported in Year 2023
ISSN (print) / ISBN 2073-4409
e-ISSN 2073-4409
Journal Cells
Quellenangaben Volume: 12, Issue: 11, Pages: , Article Number: 19 Supplement: ,
Publisher MDPI
Publishing Place Basel
Institute(s) Helmholtz Pioneer Campus (HPC)
Institute of Biological and Medical Imaging (IBMI)
POF-Topic(s) 30203 - Molecular Targets and Therapies
30205 - Bioengineering and Digital Health
Research field(s) Pioneer Campus
Enabling and Novel Technologies
PSP Element(s) G-510009-001
G-505500-001
Grants German Center for Lung Research (DZL)
Scopus ID 85161338013
PubMed ID 37296588
Erfassungsdatum 2023-10-06